Cerebrovascular Accident (CVA/Stroke) and Cerebral Hemorrhage vs. TIA — Clinical Documentation Guide (2026)

This Clinical Documentation Guide (CDG) provides AAPC/AHIMA-credentialed coders and CDI specialists with comprehensive guidance for cerebrovascular accident (CVA/stroke), cerebral hemorrhage, and transient ischemic attack (TIA). Content reflects FY2026 ICD-10-CM Official Guidelines (effective October 1, 2025), CMS HCC v28 risk adjustment mappings, and current CDI best practices. The acute vs. sequelae distinction is the single highest-impact documentation issue in this category — affecting HCC capture, MS-DRG assignment, and audit defensibility in every care setting.

🔍 1. Definition

A Cerebrovascular Accident (CVA), commonly called a stroke, is the sudden onset of neurological deficits caused by disruption of blood supply to the brain — either by ischemia (blockage) or hemorrhage (rupture). Per the American Stroke Association, stroke is the fifth leading cause of death and the leading cause of adult disability in the United States.

There are two major categories for acute stroke coding:

• Ischemic stroke (I63.x): Caused by thrombosis or embolism occluding cerebral or precerebral arteries, accounting for approximately 87% of all strokes. Per CDC stroke statistics, ischemic stroke is the predominant type in Medicare populations.
• Hemorrhagic stroke (I60.x, I61.x, I62.x): Caused by rupture of a blood vessel, leading to subarachnoid hemorrhage (I60.x), intracerebral hemorrhage (I61.x), or other nontraumatic intracranial hemorrhage (I62.x). Higher mortality than ischemic stroke.

A Transient Ischemic Attack (TIA) (G45.x) is a brief episode of neurological dysfunction from focal brain or retinal ischemia that resolves completely within 24 hours (typically minutes), with no infarction on neuroimaging. TIA is coded separately from stroke and carries distinct HCC implications — critically, TIA is NOT an HCC under CMS HCC v28.

Critical ICD-10-CM distinction: Acute stroke codes (I60–I67) are used only for the inpatient acute episode. Subsequent outpatient encounters for persistent neurological deficits use sequelae codes (I69.x), which are the primary HCC drivers for ongoing risk adjustment per FY2026 Official Guidelines Section I.C.9.d.

🗂️ 2. Alternative Terminology

Clinical documentation uses a wide variety of terms for stroke, hemorrhage, and related conditions. CDI specialists must recognize these lay and clinical terms and query for specificity when needed.

🩺 3. Signs & Symptoms

Per the American Stroke Association, stroke symptoms depend on the vessel occluded or ruptured and the brain region affected. Acute stroke symptoms typically have sudden onset.

Acute Stroke Presentation (FAST criteria and beyond)

• Facial droop: Unilateral facial weakness or asymmetry
• Arm weakness: Sudden unilateral arm or leg weakness (hemiparesis/hemiplegia)
• Speech difficulty: Aphasia, dysarthria, slurred speech, word-finding difficulty
• Time/sudden onset: Sudden severe headache "worst headache of life" (SAH hallmark)
• Vision changes: Amaurosis fugax, homonymous hemianopsia, diplopia
• Ataxia/balance: Sudden vertigo, incoordination, gait instability (posterior circulation)
• Altered consciousness: Confusion, stupor, coma (large hemisphere or brainstem involvement)
• Dysphagia: Swallowing difficulty — critical documentation target for HCC 151
• Neglect/inattention: Visuospatial neglect, spatial inattention (right hemisphere)

TIA Distinguishing Features (G45.x)

• Symptoms identical to stroke but resolve completely, typically within minutes to hours, always within 24 hours
• No infarction on DWI-MRI
• ABCD2 score used clinically to risk-stratify short-term stroke risk
• If MRI confirms infarct: code I63.x, NOT G45.x — this distinction is critical per FY2026 ICD-10-CM Official Guidelines

Hemorrhagic Stroke-Specific Features

• SAH (I60.x): Thunderclap headache, meningismus, photophobia, nausea/vomiting, loss of consciousness
• ICH (I61.x): Gradual neurological deterioration over minutes to hours, hypertension hallmark, headache common
• Herniation signs: Ipsilateral pupil dilation, Cushing triad (hypertension, bradycardia, irregular respirations)

🧭 4. Differential Diagnosis

Accurate differential documentation is essential because several mimics of stroke lead to non-stroke ICD-10-CM codes, yet others are genuine strokes requiring full code specificity with laterality, mechanism, and artery involved.

📋 5. Clinical Indicators for Coders/CDI

These clinical indicators should be reviewed at every CVA/TIA encounter to ensure documentation supports the most accurate, specific, and clinically defensible codes possible.

🦴 6. Anatomy & Pathophysiology

Understanding cerebrovascular anatomy is essential for coders interpreting artery-specific codes and laterality requirements in I63.x and I69.x.

Cerebrovascular Anatomy Relevant to ICD-10-CM

• Anterior circulation (internal carotid artery system): Supplies frontal, parietal, and temporal lobes; includes middle cerebral artery (MCA — most common stroke territory), anterior cerebral artery (ACA)
• Posterior circulation (vertebrobasilar system): Vertebral arteries → basilar artery → posterior cerebral arteries (PCA); supplies brainstem, cerebellum, occipital lobe, thalamus
• Precerebral arteries (I63.0–I63.2, I65.x): Carotid arteries, vertebral arteries, basilar artery — occluded before reaching brain parenchyma
• Cerebral arteries (I63.3–I63.5, I66.x): MCA, ACA, PCA, cerebellar arteries — within brain parenchyma
• Circle of Willis: Anastomotic ring providing collateral flow; significance for code selection when bilateral disease present

Ischemic Stroke Pathophysiology

Per the AHA/ASA 2019 Early Management Guidelines, ischemic stroke mechanisms include:

• Large vessel atherosclerosis (thrombosis): In-situ plaque rupture with thrombosis in carotid, vertebral, basilar, or major cerebral arteries → I63.0xx (precerebral thrombosis) or I63.3xx (cerebral artery thrombosis)
• Cardioembolism: Clot from cardiac source (atrial fibrillation, valvular disease, LV thrombus) → I63.1xx (precerebral embolism) or I63.4xx (cerebral artery embolism); add I48.x for AF
• Small vessel/lacunar disease: Lipohyalinosis or microatheroma in penetrating arteries → subcortical infarcts; code I63.5xx (unspecified) or per mechanism if documented
• Cryptogenic: Undetermined cause; code I63.9 (unspecified cerebral infarction) per provider documentation

Hemorrhagic Stroke Pathophysiology

• Hypertensive ICH (I61.x): Chronic hypertension causes lipohyalinosis of small penetrating arteries (lenticulostriate, thalamoperforators) → microaneurysm formation (Charcot-Bouchard) → rupture; common locations: putamen, thalamus, pons, cerebellum, subcortical white matter
• SAH (I60.x): Most commonly from saccular (berry) aneurysm rupture at Circle of Willis branch points; blood in subarachnoid space → vasospasm → delayed ischemic deficits (code additionally I67.848 if vasospasm documented)
• Cerebral amyloid angiopathy (CAA): Beta-amyloid deposition in vessels → lobar ICH in elderly; code I68.0 (cerebral amyloid angiopathy)

💊 7. Medication Impact / Treatment

Pharmacological management of CVA/stroke is directly relevant to coding because treatment agents confirm diagnosis (e.g., tPA administration confirms acute ischemic stroke) and some medications have coding implications for adverse effects or documentation.

Acute Ischemic Stroke Reperfusion Therapy

• Alteplase (Activase, tPA) — J2997: IV thrombolysis for acute ischemic stroke within 3–4.5 hours of onset; FDA-approved. Administration confirms I63.x as acute ischemic stroke. Per AHA/ASA 2019 Stroke Guidelines, eligible patients within window benefit significantly. HCPCS J2997 for billing.
• Tenecteplase (TNKase) — Q5122: Single-bolus thrombolytic; FDA approved for ischemic stroke in 2024; Q5122 for billing. Increasing use due to administration convenience.
• Edaravone (Radicava) — J1301: Free radical scavenger; primarily used in ALS but studied in acute ischemic stroke; document indication clearly.

Antiplatelet and Anticoagulation Therapy

• Aspirin + clopidogrel (DAPT): Used in TIA/minor ischemic stroke (POINT/CHANCE trials); confirm provider documents "TIA" vs. "minor stroke" for accurate code selection
• DOACs (apixaban, rivaroxaban, dabigatran) / Warfarin: Anticoagulation for AF-related stroke prevention; AF coding (I48.x) is essential additional diagnosis when present — HCC 96 for AF
• Heparin/LMWH: Bridging anticoagulation; document indication (DVT prophylaxis vs. cardioembolic source treatment)

Blood Pressure and Neuroprotection

• Permissive hypertension protocol in acute ischemic stroke (maintain BP <185/110 for tPA candidates, <220/120 for non-tPA)
• Aggressive BP lowering in hemorrhagic stroke (goal <140 systolic per AHA/ASA 2015 ICH Guidelines)
• Statin therapy for secondary prevention in ischemic stroke (document hyperlipidemia E78.5 if present)
• Antiepileptics if post-stroke seizures develop (G40.x — code separately, major CDI opportunity)

Medications Affecting Code Selection

• Anticoagulant use: If hemorrhagic transformation occurs on anticoagulation, provider must document to assign T45.515A/D (adverse effect warfarin) or T45.525A (adverse effect DOAC)
• Nimodipine: Used for SAH to prevent vasospasm; documents SAH present (I60.x)
• Mannitol/hypertonic saline: Documents cerebral edema/herniation risk — query provider for specific documentation of herniation (G93.5) if clinical indicators present

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides